Novo: Amycretin Causes 22 Percent Weight Loss (Connecting the Dots: Barack Obama, Michelle Obama, Sidley Austin LLP, Novo Nordisk Inc., Big Pharma, Covington & Burling LLP & Soros Funding, All Networking)
Newsmax.com
Friday, 24 January 2025 07:37 AM EST
https://www.newsmax.com/health/health-news/novo-nordisk-amycretin-obesity/2025/01/24/id/1196340/
Novo Nordisk on Friday announced early-stage trial
results for its amycretin obesity drug for subcutaneous injection, saying
people with obesity or overweight treated with the drug achieved a 22% weight
loss after 36 weeks.
Shares
jumped on the release and traded up 7% at 1040 GMT.
Amycretin
targets the same gut hormone that Wegovy mimics, known as GLP-1, but also a
pancreas hormone called amylin that affects hunger.
"The
results seen in the trial support the weight lowering potential of this novel
unimolecular GLP-1 and amylin receptor agonist, amycretin, that we have
previously seen with the oral formulation," Novo Nordisk's head of
development Martin Lange said in a statement.
Novo
is also developing amycretin as a weight-loss pill, which helped obese
participants lose 13.1% of their weight after 12 weeks of treatment in an
early-stage study.
The
company said in September it plans to decide on further studies for amycretin
after data from the trial with the subcutaneous version.
Connecting
the Dots:
Sidley Austin LLP was the lobby firm
for Novo Nordisk Inc. and is the lobby firm for the Pharmaceutical
Research and Manufacturers of America (Big Pharma).
Michelle Obama was
a lawyer at Sidley Austin LLP.
Barack Obama was
an intern at Sidley Austin LLP.
Faith Elizabeth
Gay was an attorney at Sidley Austin LLP and is a
board of adviser’s member for the American Constitution Society.
Open Society Foundations was a funder
for the American Constitution Society.
George Soros is the founder & chairman for the Open
Society Foundations.
Robert Raben was
a director at the American Constitution Society, and an assistant
attorney general for the U.S. Department of Justice.
David B. Barlow was
the U.S. attorney for the District of Utah for the U.S. Department of
Justice and is a partner at Sidley Austin LLP.
Eric H. Holder Jr. was
a board member for the American Constitution Society, the attorney
general at the U.S. Department of Justice for the Barack
Obama administration and is a partner at Covington & Burling
LLP.
Covington
& Burling LLP is the lobby firm for the Pharmaceutical
Research and Manufacturers of America (Big Pharma) and was the lobby firm
for Novo Nordisk Inc.
Lars Rebien
Sorensen is the president & CEO for Novo Nordisk Inc.
and was a supervisory board member for Bertelsmann AG.
Markus Dohle is
an executive board member for Bertelsmann AG and was a
director at the Atlantic Council of the United States (think tank).
Open Society Foundations was a funder for
the Atlantic Council of the United States (think tank).
George Soros is the founder & chairman
for the Open Society Foundations.
Resources:
Past Research
This
new weight-loss drug is one you want to stay far away from (Past Research on Novo Nordisk)
Friday,
January 1, 2016
https://thesteadydrip.blogspot.com/2016/01/this-new-weight-loss-drug-is-one-you.html
No comments:
Post a Comment